The drug eluting balloon (DEB) market has emerged as an effective treatment option for coronary artery disease. DEBs are angioplasty balloons coated with an antiproliferative drug to prevent re-narrowing of coronary arteries. The balloons are used in percutaneous coronary intervention (PCI) to deliver the drug to the treatment site during angioplasty procedures. DEBs offer advantages over drug eluting stents such as lower risks of stent fracture and thrombosis. The growing prevalence of ... Read more
